Cargando…

Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer

Introduction: In the past decade, super-enhancer (SE) has become a research hotspot with increasing attention on cancer occurrence, development, and prognosis. To illustrate the hotspots of SE in cancer research and its evolutionary tendency, bibliometric analysis was carried out for this topic. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zhen-Chu, Qu, Qiang, Teng, Xin-Qi, Zhuang, Hai-Hui, Xu, Wei-Xin, Qu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415222/
https://www.ncbi.nlm.nih.gov/pubmed/37576806
http://dx.doi.org/10.3389/fphar.2023.1192855
_version_ 1785087480888819712
author Tang, Zhen-Chu
Qu, Qiang
Teng, Xin-Qi
Zhuang, Hai-Hui
Xu, Wei-Xin
Qu, Jian
author_facet Tang, Zhen-Chu
Qu, Qiang
Teng, Xin-Qi
Zhuang, Hai-Hui
Xu, Wei-Xin
Qu, Jian
author_sort Tang, Zhen-Chu
collection PubMed
description Introduction: In the past decade, super-enhancer (SE) has become a research hotspot with increasing attention on cancer occurrence, development, and prognosis. To illustrate the hotspots of SE in cancer research and its evolutionary tendency, bibliometric analysis was carried out for this topic. Methods: Literature published before Dec 31, 2022, in WOSCC, was systematically classified, and Citespace, bibliometric.com/app, and GraphPad Prism analyzed the data. Results: After screening out inappropriate documents and duplicate data, 911 publications were selected for further bibliometric analysis. The top five research areas were Oncology (257, 28.211%), Cell Biology (210, 23.052%), Biochemistry Molecular Biology (209, 22.942%), Science Technology Other Topics (138, 15.148%), and Genetics Heredity (132, 14.490%). The United States of America (United States) has the highest number of documents (462, 50.71%), followed by China (303, 33.26%). Among the most productive institutions, four of which are from the United States and one from Singapore, the National University of Singapore. Harvard Medical School (7.68%) has the highest percentage of articles. Young, Richard A, with 32 publications, ranks first in the number of articles. The top three authors came from Whitehead Institute for Biomedical Research as a research team. More than two-thirds of the research are supported by the National Institutes of Health of the United States (337, 37.654%) and the United States Department of Health Human Services (337, 37.654%). And “super enhancer” (525), “cell identity” (258), “expression” (223), “cancer” (205), and “transcription factor” (193) account for the top 5 occurrence keywords. Discussion: Since 2013, SE and cancer related publications have shown a rapid growth trend. The United States continues to play a leading role in this field, as the top literature numbers, affiliations, funding agencies, and authors were all from the United States, followed by China and European countries. A high degree of active cooperation is evident among a multitude of countries. The role of SEs in cell identity, gene transcription, expression, and inhibition, as well as the relationship between SEs and TFs, and the selective inhibition of SEs, have received much attention, suggesting that they are hot issues for research.
format Online
Article
Text
id pubmed-10415222
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104152222023-08-12 Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer Tang, Zhen-Chu Qu, Qiang Teng, Xin-Qi Zhuang, Hai-Hui Xu, Wei-Xin Qu, Jian Front Pharmacol Pharmacology Introduction: In the past decade, super-enhancer (SE) has become a research hotspot with increasing attention on cancer occurrence, development, and prognosis. To illustrate the hotspots of SE in cancer research and its evolutionary tendency, bibliometric analysis was carried out for this topic. Methods: Literature published before Dec 31, 2022, in WOSCC, was systematically classified, and Citespace, bibliometric.com/app, and GraphPad Prism analyzed the data. Results: After screening out inappropriate documents and duplicate data, 911 publications were selected for further bibliometric analysis. The top five research areas were Oncology (257, 28.211%), Cell Biology (210, 23.052%), Biochemistry Molecular Biology (209, 22.942%), Science Technology Other Topics (138, 15.148%), and Genetics Heredity (132, 14.490%). The United States of America (United States) has the highest number of documents (462, 50.71%), followed by China (303, 33.26%). Among the most productive institutions, four of which are from the United States and one from Singapore, the National University of Singapore. Harvard Medical School (7.68%) has the highest percentage of articles. Young, Richard A, with 32 publications, ranks first in the number of articles. The top three authors came from Whitehead Institute for Biomedical Research as a research team. More than two-thirds of the research are supported by the National Institutes of Health of the United States (337, 37.654%) and the United States Department of Health Human Services (337, 37.654%). And “super enhancer” (525), “cell identity” (258), “expression” (223), “cancer” (205), and “transcription factor” (193) account for the top 5 occurrence keywords. Discussion: Since 2013, SE and cancer related publications have shown a rapid growth trend. The United States continues to play a leading role in this field, as the top literature numbers, affiliations, funding agencies, and authors were all from the United States, followed by China and European countries. A high degree of active cooperation is evident among a multitude of countries. The role of SEs in cell identity, gene transcription, expression, and inhibition, as well as the relationship between SEs and TFs, and the selective inhibition of SEs, have received much attention, suggesting that they are hot issues for research. Frontiers Media S.A. 2023-07-27 /pmc/articles/PMC10415222/ /pubmed/37576806 http://dx.doi.org/10.3389/fphar.2023.1192855 Text en Copyright © 2023 Tang, Qu, Teng, Zhuang, Xu and Qu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tang, Zhen-Chu
Qu, Qiang
Teng, Xin-Qi
Zhuang, Hai-Hui
Xu, Wei-Xin
Qu, Jian
Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
title Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
title_full Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
title_fullStr Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
title_full_unstemmed Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
title_short Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
title_sort bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415222/
https://www.ncbi.nlm.nih.gov/pubmed/37576806
http://dx.doi.org/10.3389/fphar.2023.1192855
work_keys_str_mv AT tangzhenchu bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer
AT quqiang bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer
AT tengxinqi bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer
AT zhuanghaihui bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer
AT xuweixin bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer
AT qujian bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer